IP Library Granted Patent US 11,154,496
Granted Patent B2
US 11,154,496 · App. 16/257,914 · Granted Oct 26, 2021

Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Inventors: Heidi Ziegler Bruun (Vejle Ost, DK); Dorthe Schackinger Boesen (Vejle, DK); Ane Eriksen (Vejle, DK)
A61K9/0058A23G4/068A23G4/08A23G4/10A23G4/12A23G4/20A61K31/05A61K31/192A61K31/352A61K36/185A61K47/32A61K47/61A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,496
App. No.
16/257,914
Granted
Oct 26, 2021
Kind
B2
Abstract

The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the gum base has one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the one or more elastomer plasticizers includes one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the chewing gum has one or more cannabinoids.

Claims (41)

1. A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base, the water-insoluble gum base including gum base polymers,

the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 10-40% by weight of the gum base,

wherein the one or more elastomer plasticizers comprises one or more polyvinyl acetate elastomer plasticizers in an amount of 10-40% by weight of the gum base,

wherein the gum base polymers comprise less than 5% by weight of vinyl laurate-vinyl acetate copolymer, and

wherein the chewing gum comprises one or more cannabinoids.

2. The chewing gum according to claim 1 , wherein the one or more cannabinoids is homogeneously distributed in the water-insoluble gum base comprising the one or more polyvinyl acetate elastomer plasticizers.

3. The chewing gum according to claim 1 , wherein the one or more cannabinoids is embedded in the water-insoluble gum base comprising the one or more polyvinyl acetate elastomer plasticizers.

4. The chewing gum according to claim 1 , wherein the release rate of the one or more cannabinoids is at least 10% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

5. The chewing gum according to claim 1 , wherein the one or more cannabinoids is mixed into the water-insoluble gum base in unbound form.

6. The chewing gum according to claim 1 , wherein at least 10% by weight of the one or more cannabinoids is present in unbound form.

7. The chewing gum according to claim 1 , wherein the one or more elastomer plasticizers is present in an amount of 10-35% by weight of the gum base and comprises the one or more polyvinyl acetate elastomer plasticizers in an amount of 15-35% by weight of the gum base.

8. The chewing gum according to claim 1 , wherein the one or more natural resins is present in an amount of 15-35% by weight of the gum base.

9. The chewing gum according to claim 1 , wherein the chewing gum comprises water-soluble chewing gum ingredients in an amount of 40-70% by weight of the chewing gum.

10. The chewing gum according to claim 1 , wherein the one or more cannabinoids is mixed into the water-insoluble gum base together with sugar alcohols or saccharose after a period of more than half the total mixing time.

11. The chewing gum according to claim 1 , wherein the one or more cannabinoids is mixed into the water-insoluble gum base as part of a pre-mixture with water-soluble chewing gum ingredients.

12. The chewing gum according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), and combinations thereof.

13. The chewing gum according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), and combinations thereof.

14. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises cannabigerol (CBG).

15. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least two cannabinoids.

16. The chewing gum according to claim 1 , wherein the one or more cannabinoids is present in a pre-mixture with one or more sugar alcohols or saccharose.

17. The chewing gum according to claim 1 , wherein the one or more cannabinoids forms part of a complex with cyclodextrin.

18. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one phytocannabinoid that forms part of an extract.

19. The chewing gum according to claim 1 , wherein the chewing gum further comprises terpenes.

20. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one isolated cannabinoid.

21. The chewing gum according to claim 1 , wherein the one or more cannabinoids comprises at least one water-soluble cannabinoid.

22. The chewing gum according to claim 1 , wherein the chewing gum comprises a self-emulsifying agent.

23. The chewing gum according to claim 1 , wherein the one or more cannabinoids is comprised in an outer coating of the chewing gum.

24. The chewing gum according to claim 1 , wherein the gum base does not comprise vinyl laurate-vinyl acetate copolymers.

25. A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base,

the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base,

wherein the one or more elastomer plasticizers comprises one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base,

wherein the chewing gum comprises one or more cannabinoids,

wherein the gum base comprises less than 50% by weight of gum base polymers,

and

wherein the gum base polymers comprise less than 5% by weight of vinyl laurate-vinyl acetate copolymer.

26. A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base,

the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base,

wherein the one or more elastomer plasticizers comprises one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base,

wherein the gum base does not comprise vinyl laurate-vinyl acetate copolymers, and

wherein the chewing gum comprises one or more cannabinoids.

27. The chewing gum according to claim 26 , wherein the one or more elastomer plasticizers is present in an amount of 10-40% by weight of the gum base and comprises the one or more polyvinyl acetate elastomer plasticizers in an amount of 10-40% by weight of the gum base.

Assignments (3)
CHANGE OF NAME Recorded Oct 1, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053967/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2019
From: BRUUN, HEIDI ZIEGLER; BOESEN, DORTHE SCHACKINGER; ERIKSEN, ANE
To: FERTIN PHARMA A/S
Reel/Frame 048920/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2019
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 048921/0660 →
Continuity (1)
Related Publication 20200237660A1 · Jul 30, 2020
Cited By (1)
US 12,629,332